Al-Chalabi A, Durr A, Wood NW, Parkinson MH, Camuzat A, Hulot JS, Morrison KE, Renton A, Sussmuth SD, Landwehrmeyer BG, Ludolph A, Agid Y, Brice A, Leigh PN, Bensimon G. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 2009; 4: e7114.
Asahina M, Akaogi Y, Yamanaka Y, Koyama Y, Hattori T. Differences in skin sympathetic involvements between two chronic autonomic disorders: multiple system atrophy and pure autonomic failure. Parkinsonism Relat Disord 2009; 15: 347-50.
Barnes CS, Yan J, Wilmot GR. A negative electroretinogram (ERG) in a case of probable multiple system atrophy (MSA). Doc Ophthalmol 2009; 118: 247-56.
Benarroch EE, Schmeichel AM, Dugger BN, Sandroni P, Parisi JE, Low PA. Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia. Neurology 2009; 73: 106-12.
Brooks DJ, Seppi K. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 2009; 24: 949-64.
Buttarelli FR, Circella A, Pellicano C, Tiple D, Giovannelli M, Colosimo C, Pontieri FE. Dopamine transporter immunoreactivity in peripheral blood lymphocytes in multiple system atrophy. J Neural Transm 2009; 116: 161-5.
Chandran V, Pal PK, Moin A, Chickabasaviah YT, Ravishankar S, Panda S. Erdheim-Chester disease: a rare clinical presentation as multiple system atrophy. Mov Disord 2009; 24: 461-3.
Chang CC, Chang YY, Chang WN, Lee YC, Wang YL, Lui CC, Huang CW, Liu WL. Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration. Eur J Neurol 2009; 16: 1144-50.
Chang MH, Hung WL, Liao YC, Lee YC, Hsieh PF. Eye of the tiger-like MRI in parkinsonian variant of multiple system atrophy. J Neural Transm 2009; 116: 861-6.
Cho JW, Kim SY, Park SS, Jeon BS. The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson's Disease and Multiple System Atrophy. J Clin Neurol 2009; 5: 29-32.
Chung EJ, Lee WY, Yoon WT, Kim BJ, Lee GH. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy. Mov Disord 2009; 24: 1650-5.
Di Filippo M, Floridi P, Rossi V, Mattucci E, Rossi A, Calabresi P, Tambasco N. A young patient with type C multiple system atrophy and hereditary hemochromatosis. J Neurol; 257: 294-5.
Estevez S, Perez-Lloret S, Merello M. Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD? Int J Neurosci 2009; 119: 2257-61.
Feng F, You H, Wang H, Zheng FL, Jin ZY, Cui LY. [Phase-weighted imaging in differentiating multiple system atrophy from idiopathic Parkinson disease]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2009; 31: 129-33.
Finke C, Siebert E, Plotkin M, Wenning GK, Reuter U. Multiple system atrophy masking multiple sclerosis. Clin Neurol Neurosurg; 112: 59-61.
Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy. J Urol 2009; 182: 1453-7.
Ito S, Shirai W, Hattori T. Putaminal hyperintensity on T1-weighted MR imaging in patients with the Parkinson variant of multiple system atrophy. AJNR Am J Neuroradiol 2009; 30: 689-92.
Kamitani T, Kuroiwa Y. Visual event-related potential changes in multiple system atrophy: delayed N2 latency in selective attention to a color task. Parkinsonism Relat Disord 2009; 15: 36-40.
Kao AW, Racine CA, Quitania LC, Kramer JH, Christine CW, Miller BL. Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. Alzheimer Dis Assoc Disord 2009; 23: 365-70.
Kashihara K, Ohno M. Multiple system atrophy with antecollis that later changed to an extended posture: a case report. Mov Disord 2009; 24: 939-40.
Kimura N, Kumamoto T, Masuda T, Nomura Y, Hanaoka T, Hazama Y, Okazaki T. Evaluation of regional cerebral blood flow in cerebellar variant of multiple system atrophy using FineSRT. Clin Neurol Neurosurg 2009; 111: 829-34.
Kitayama M, Wada-Isoe K, Irizawa Y, Nakashima K. Assessment of dementia in patients with multiple system atrophy. Eur J Neurol 2009; 16: 589-94.
Kollensperger M, Stefanova N, Pallua A, Puschban Z, Dechant G, Hainzer M, Reindl M, Poewe W, Nikkhah G, Wenning GK. Striatal transplantation in a rodent model of multiple system atrophy: effects on L-Dopa response. J Neurosci Res 2009; 87: 1679-85.
Kuzniar TJ, Morgenthaler TI, Prakash UB, Pallanch JF, Silber MH, Tippmann-Peikert M. Effects of continuous positive airway pressure on stridor in multiple system atrophy-sleep laryngoscopy. J Clin Sleep Med 2009; 5: 65-7.
Landers M, Adams M, Acosta K, Fox A. Challenge-oriented gait and balance training in sporadic olivopontocerebellar atrophy: a case study. J Neurol Phys Ther 2009; 33: 160-8.
Lee JY, Lee WW, Kim JS, Kim HJ, Kim JK, Jeon BS. Perverted head-shaking and positional downbeat nystagmus in patients with multiple system atrophy. Mov Disord 2009; 24: 1290-5.
Lee PH, Lim TS, Shin HW, Yong SW, Nam HS, Sohn YH. Serum cholesterol levels and the risk of multiple system atrophy: a case-control study. Mov Disord 2009; 24: 752-8.
Lee PH, Park HJ. Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy. J Clin Neurol 2009; 5: 1-10.
Lim SY, Wadia P, Wenning GK, Lang AE. Clinically probable multiple system atrophy with predominant parkinsonism associated with myotonic dystrophy type 2. Mov Disord 2009; 24: 1407-9.
Lim TS, Lee PH, Kim HS, Yong SW. White matter hyperintensities in patients with multiple system atrophy. J Neurol 2009; 256: 1663-70.
Lipp A, Sandroni P, Ahlskog JE, Fealey RD, Kimpinski K, Iodice V, Gehrking TL, Weigand SD, Sletten DM, Gehrking JA, Nickander KK, Singer W, Maraganore DM, Gilman S, Wenning GK, Shults CW, Low PA. Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol 2009; 66: 742-50.
Lipp A, Sandroni P, Low PA. Systemic postganglionic adrenergic studies do not distinguish Parkinson's disease from multiple system atrophy. J Neurol Sci 2009; 281: 15-9.
Matsusue E, Fujii S, Kanasaki Y, Kaminou T, Ohama E, Ogawa T. Cerebellar lesions in multiple system atrophy: postmortem MR imaging-pathologic correlations. AJNR Am J Neuroradiol 2009; 30: 1725-30.
Miyatake S, Mochizuki H, Naka T, Ugawa Y, Tanabe H, Kuzume D, Suzuki M, Ogata K, Kawai M. Brain volume analyses and somatosensory evoked potentials in multiple system atrophy. J Neurol; 257: 419-25.
Munhoz RP, Teive HA, Raskin S, Werneck LC. CTA/CTG expansions at the SCA 8 locus in multiple system atrophy. Clin Neurol Neurosurg 2009; 111: 208-10.
Nakajima M, Kojima H, Takazawa Y, Yahagi N, Harada K, Takahashi K, Unuma K, Yoshida K. An autopsy report on multiple system atrophy diagnosed immunohistochemically despite severe ischaemic damage: a new approach for investigation of medical practice associated deaths in Japan. J Clin Pathol 2009; 62: 1029-33.
Nakayama K, Suzuki Y, Yazawa I. Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy. Am J Pathol 2009; 174: 1471-80.
Nam H, Hong YH, Kwon HM, Cho J. Does multiple system atrophy itself affect sleep structure? Neurologist 2009; 15: 274-6.
Nishizawa M, Shimohata T. [Clinical features of multiple system atrophy]. Rinsho Shinkeigaku 2009; 49: 249-53.
Novak P, Marya NB, Whren K, Bhawan J. Dermal sheet preparations in the evaluation of dermal innervation in Parkinson's disease and multiple system atrophy. J Cutan Pathol 2009; 36: 296-301.
Ogawa T, Oodaira H, Suzuki Y, Hashimoto R, Kato H. [Successive application of percutaneous endoscopic gastrostomy with jejunal extension and percutaneous endoscopic jejunostomy in a case of multiple system atrophy]. Rinsho Shinkeigaku 2009; 49: 370-3.
Oishi K, Konishi J, Mori S, Ishihara H, Kawamitsu H, Fujii M, Kanda F. Reduced fractional anisotropy in early-stage cerebellar variant of multiple system atrophy. J Neuroimaging 2009; 19: 127-31.
Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP. A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord 2009; 24: 2272-6.
Pellecchia MT, Barone P, Mollica C, Salvatore E, Ianniciello M, Longo K, Varrone A, Vicidomini C, Picillo M, De Michele G, Filla A, Salvatore M, Pappata S. Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord 2009; 24: 689-96.
Petzold A, Thompson EJ, Keir G, Quinn N, Holmberg B, Dizdar N, Wenning GK, Rascol O, Tolosa E, Rosengren L. Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy. J Neurol Sci 2009; 279: 76-9.
Pezzoli G, Tesei S, Canesi M, Sacilotto G, Vittorio M, Mizuno Y, Mochizuki H, Antonini A. The effect of repeated administrations of granulocyte colony stimulating factor for blood stem cells mobilization in patients with progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy. Clin Neurol Neurosurg; 112: 65-7.
Pinkhardt EH, Kassubek J, Sussmuth S, Ludolph AC, Becker W, Jurgens R. Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease. J Neurol 2009; 256: 1438-46.
Pinnock RA, McGivern RC, Forbes R, Gibson JM. An exploration of ocular fixation in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. J Neurol; 257: 533-9.
Pountney DL, Dickson TC, Power JH, Vickers JC, West AJ, Gai WP. Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy. Neurotox Res; 19: 115-22.
Prakash N, Hageman N, Hua X, Toga AW, Perlman SL, Salamon N. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes. Neuroimage 2009; 47 Suppl 2: T72-81.
Reimann M, Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schoels L, Reichmann H, Berg D, Ziemssen T. Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. J Neural Transm; 117: 69-76.
Sakakibara Y, Asahina M, Suzuki A, Hattori T. Gastric myoelectrical differences between Parkinson's disease and multiple system atrophy. Mov Disord 2009; 24: 1579-86.
Sakurai K, Kawaguchi T, Kawai T, Ogino H, Hara M, Okita K, Yamawaki T, Shibamoto Y. Usefulness of 3D-PRESTO imaging in evaluating putaminal abnormality in parkinsonian variant of multiple system atrophy. Neuroradiology; 52: 809-14.
Salazar G, Casas E, Oliveras D, Rando A, Sergio P. Ocular-jaw synkinesia in normal, Parkinson's disease, and multiple system atrophy subjects: Clinical and electrophysiological findings. Clin Neurophysiol; 121: 94-7.
Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wullner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Del Sorbo F, Schneider S, Bhatia KP, Gasser T. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009; 65: 610-4.
Segarane B, Li A, Paudel R, Scholz S, Neumann J, Lees A, Revesz T, Hardy J, Mathias CJ, Wood NW, Holton J, Houlden H. Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology 2009; 72: 1185-6.
Silveira-Moriyama L, Gonzalez AM, O'Sullivan SS, Williams DR, Massey L, Parkkinen L, Ahmed Z, de Silva R, Chacon JR, Revesz T, Lees AJ, Holton JL. Concomitant progressive supranuclear palsy and multiple system atrophy: more than a simple twist of fate? Neurosci Lett 2009; 467: 208-11.
Stefanova N, Bucke P, Duerr S, Wenning GK. Multiple system atrophy: an update. Lancet Neurol 2009; 8: 1172-8.
Stefanova N, Hainzer M, Stemberger S, Couillard-Despres S, Aigner L, Poewe W, Wenning GK. Striatal transplantation for multiple system atrophy--are grafts affected by alpha-synucleinopathy? Exp Neurol 2009; 219: 368-71.
Suzuki M, Saigusa H, Shibasaki K, Kodera K. Multiple system atrophy manifesting as complex sleep-disordered breathing. Auris Nasus Larynx; 37: 110-3.
Swash M. Apraxia contributes to the motor deficit in Parkinson's Disease and multiple system atrophy. Eur J Neurol; 17: 346-7.
Tada M, Kakita A, Toyoshima Y, Onodera O, Ozawa T, Morita T, Nishizawa M, Takahashi H. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death. Brain 2009; 132: 1810-9.
Takei A, Hamada S, Homma S, Hamada K, Tashiro K, Hamada T. Amelioration of subacute camptocormia in multiple system atrophy by protirelin tartrate. Mov Disord 2009; 24: 2022-3.
Tezuka T, Ozawa T, Takado Y, Sato Y, Oyake M, Nishizawa M. Megacolon in multiple system atrophy: safety concerns related to PEG. Mov Disord 2009; 24: 1096-7.
Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain; 133: 172-88.
Torny F, Lacoste M, Videaud H, Chouly M, Parveau MC, Couratier P. [Comparison of quality of life in multiple system atrophy and Parkinson's disease]. Rev Neurol (Paris) 2009; 165: 911-5.
Tzarouchi LC, Astrakas LG, Konitsiotis S, Tsouli S, Margariti P, Zikou A, Argyropoulou MI. Voxel-based morphometry and Voxel-based relaxometry in parkinsonian variant of multiple system atrophy. J Neuroimaging; 20: 260-6.
Ubhi K, Lee PH, Adame A, Inglis C, Mante M, Rockenstein E, Stefanova N, Wenning GK, Masliah E. Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy. J Neurosci Res 2009; 87: 2728-39.
Uluduz D, Erturk O, Kenangil G, Ozekmekci S, Ertan S, Apaydin H, Erginoz E. Apraxia in Parkinson's disease and multiple system atrophy. Eur J Neurol; 17: 413-8.
Uyama N, Uchihara T, Mochizuki Y, Nakamura A, Takahashi R, Mizutani T. Selective nuclear shrinkage of oligodendrocytes lacking glial cytoplasmic inclusions in multiple system atrophy: a 3-dimensional volumetric study. J Neuropathol Exp Neurol 2009; 68: 1084-91.
Vetrugno R, Alessandria M, D'Angelo R, Plazzi G, Provini F, Cortelli P, Montagna P. Status dissociatus evolving from REM sleep behaviour disorder in multiple system atrophy. Sleep Med 2009; 10: 247-52.
Wenning GK, Brown R. Dementia in multiple system atrophy: does it exist? Eur J Neurol 2009; 16: 551-2.
Wenning GK, Stefanova N. Recent developments in multiple system atrophy. J Neurol 2009; 256: 1791-808.
Wu YT, Shyu KK, Jao CW, Wang ZY, Soong BW, Wu HM, Wang PS. Fractal dimension analysis for quantifying cerebellar morphological change of multiple system atrophy of the cerebellar type (MSA-C). Neuroimage; 49: 539-51.
Wullner U, Schmitt I, Kammal M, Kretzschmar HA, Neumann M. Definite multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry 2009; 80: 449-50.
Xu WH, Wang H, Wang B, Niu FS, Gao S, Cui LY. Disparate cardio-cerebral vascular modulation during standing in multiple system atrophy and Parkinson disease. J Neurol Sci 2009; 276: 84-7.
Yamamoto T, Sakakibara R, Uchiyama T, Liu Z, Ito T, Awa Y, Yamanishi T, Hattori T. Questionnaire-based assessment of pelvic organ dysfunction in multiple system atrophy. Mov Disord 2009; 24: 972-8.
Yoshida M, Sone M. [Mechanism of neuronal degeneration of multiple system atrophy]. Brain Nerve 2009; 61: 1051-60.
Yoshihara T, Yamamura Y, Kaneko F, Abo N, Nomoto M. Neuromuscular junctions of the posterior cricoarytenoid muscle in multiple system atrophy: a case study. Acta Otolaryngol Suppl 2009: 115-9.